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Yeast is a powerful model for systems genetics. We present a versatile, time- and labor-19 
efficient method to functionally explore the Saccharomyces cerevisiae genome using 20 
saturated transposon mutagenesis coupled to high-throughput sequencing. SAturated 21 
Transposon Analysis in Yeast (SATAY) allows one-step mapping of all genetic loci in which 22 
transposons can insert without disrupting essential functions. SATAY is particularly suited 23 
to discover loci important for growth under various conditions. SATAY (1) reveals positive 24 
and negative genetic interactions in single and multiple mutant strains, (2) can identify 25 
drug targets, (3) detects not only essential genes, but also essential protein domains, (4) 26 
generates both null and other informative alleles. In a SATAY screen for rapamycin-27 
resistant mutants, we identify Pib2 (PhosphoInositide-Binding 2) as a master regulator of 28 
TORC1. We describe two antagonistic TORC1-activating and -inhibiting activities located 29 
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on opposite ends of Pib2. Thus, SATAY allows to easily explore the yeast genome at 30 
unprecedented resolution and throughput. 31 
 32 
Introduction 33 
Saccharomyces cerevisiae is an invaluable model for cell biology (Weissman, 2010). Despite the 34 
simplicity of its genome, its inner working mechanisms are similar to that of higher eukaryotes. 35 
Furthermore, its ease of handling allows large-scale screenings. Yeast genetic screens have classically 36 
been performed by random mutagenesis, followed by a selection process that identifies interesting 37 
mutants. However elegant the “tricks” implemented to expose the sought-after mutants, this 38 
selection phase remains a tedious process of finding a needle-in-a-haystack (Weissman, 2010). The 39 
selection phase can limit the throughput and the saturation of classical yeast genetic screens. 40 
To circumvent these problems, a second-generation genetic screening procedure has been developed. 41 
Ordered deletion libraries for every non-essential gene have been generated (Giaever et al., 2002). 42 
The growth of each individual deletion strain can be assessed, either by robot-mediated arraying, or 43 
by competitive growth of pooled deletion strains, followed by detection of “barcodes” that identify 44 
each deletion strain. These second-generation approaches also have limitations. First, ordered 45 
libraries of complete deletions only cover non-essential genes. Second, deletion strains are prone to 46 
accumulate suppressor mutations (Teng et al., 2013). To alleviate these problems, deletion libraries 47 
can be propagated in a diploid-heterozygous form. Additional steps are then required to make them 48 
haploid. In addition, while single genetic traits can be crossed into a pre-existing library, allowing for 49 
instance pairwise genetic-interaction analysis (Costanzo et al., 2010), introducing multiple and/or 50 
sophisticated genetic perturbations becomes problematic, since crossing requires a selection marker 51 
for each important trait. Typically, deletion libraries are missing in most biotechnology-relevant 52 
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backgrounds. Finally, manipulating ordered libraries requires non-standard equipment, such as 53 
arraying robots, limiting the pervasiveness of these approaches. 54 
Recently, an innovative approach called Transposon sequencing (Tn-seq) was developed in several 55 
bacterial models, and allows en masse analysis of a pool of transposon mutants using next-generation 56 
sequencing (Christen et al., 2011; Girgis et al., 2007; van Opijnen et al., 2009). This approach 57 
alleviates the limitations of previous genetic screens, but is restricted to prokaryotes. 58 
Here, we describe an adaptation of the Tn-seq strategy for eukaryotic genomes, that combines the 59 
advantages of both first and second generation screens, while alleviating their limitations. The 60 
method is based on the generation of libraries of millions of different clones by random transposon 61 
insertion (Figure 1A). Transposons inserted in genes that are important for growth kill their hosts and 62 
are not subsequently detected. These genes therefore constitute transposon-free areas on the 63 
genomic map. Transposon-based libraries can be grown in any condition to reveal condition-specific 64 
genetic requirements. Unlike ordered deletion libraries, transposon-based libraries can easily be 65 
generated de novo from different strain backgrounds, are not limited to coding sequences and do not 66 
require the usage of robots.  67 
This method can successfully uncover sets of genes essential in given conditions, genome-wide 68 
genetic interactions and drug-targets. Transposon insertions can generate loss- and gain-of-function 69 
variants. Finally, our approach not only shows which protein is important for growth, but also which 70 
part of the protein is essential for function, allowing genome-wide mapping of structural protein 71 
domains and screening of phenotypes at a sub-gene resolution. 72 
Results 73 
Library generation 74 
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The detailed procedure can be found in the Methods section. The method utilizes the Maize Ac/Ds 75 
transposase /transposon system in yeast (Lazarow et al., 2012; Weil and Kunze, 2000). Briefly, cells in 76 
which the ADE2 gene is interrupted by the MiniDs transposon are induced to express the transposase 77 
Ac, on galactose-containing adenine-lacking synthetic defined medium (SD +galactose -adenine). 78 
Transposase-induced MiniDs excision is followed by repair of the ADE2 gene. Cells with repaired ADE2 79 
will be able to form colonies. The excised transposon then re-inserts at random genomic locations 80 
with a frequency of ~60% (Lazarow et al., 2012).  81 
We have generated seven libraries, displayed together in all figures to illustrate the reproducibility of 82 
the approach. All libraries were generated in ade2Δ strains derived from BY4741 and BY4742 83 
backgrounds. Additional mutations (dpl1Δ, dpl1Δ psd2Δ, VPS13(D716H), mmm1Δ VPS13(D716H), 84 
YEN1on, Table 1) will be described in the following sections. The complete dataset is available 85 
(Supplementary File 1) and searchable here: 86 
http://genome-euro.ucsc.edu/cgi-87 
bin/hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=benjou&hgS_otherUserSessionNam88 
e=23bDePuYrk 89 
Detection of transposon insertion sites 90 
Typically 7,000-10,000 colonies with a narrow size distribution (Figure 1 – figure supplement 1) can 91 
be generated on a 8.4 cm-Ø petri dish. In the case of wild-type library 1, 240 plates yielded ~1.6E6 92 
clones (Table 1). To detect transposon insertion sites, transposed cells were scraped off the 240 plates 93 
and pooled (Figure 1A). This pool was used to reinocculate SD medium lacking adenine (SD +Dextrose 94 
-Adenine), and the culture was grown to saturation. This step was used to dilute non-transposed ade- 95 
cells still present on the petri dishes. The culture was then harvested by centrifugation. Genomic DNA 96 
was extracted and digested with frequent-cutting restriction enzymes, followed by ligase-mediated 97 
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intramolecular circularization. Circular DNA was PCR-amplified using transposon-specific outwards-98 
facing primers. PCR products were then sequenced on a MiSeq machine (Figure 1A). 99 
Analysis of transposon insertion sites 100 
We aligned the sequencing reads of the wild-type library (Table 1) to the reference yeast genome and 101 
counted the number of mapped transposons. To account for the fact that Illumina sequencing is 102 
imperfectly accurate, we considered that two reads of the same orientation mapping within two bp of 103 
each other originated from the same transposon (see MatLab Script 1). In this analysis, 284,162 104 
independent transposons could be mapped onto the genome, representing an average density of one 105 
transposon every 42 bp, and a median number of 22 reads per transposon. No large area of the 106 
genome was devoid of transposon (Figure 1B). Consistent with analyses in Maize (Vollbrecht et al., 107 
2010), no strong sequence preference was detected in the insertion sites (Figure 1 – figure 108 
supplement 2A).  109 
In many instances, though, insertion frequency was modulated along the genome with a periodicity 110 
of ~160 bp. Superimposing nucleosome occupancy data (Lee et al., 2007) showed that this was due 111 
to favored transposon insertion in inter-nucleosomal DNA (Figure 1 – figure supplement 2B). This 112 
effect can be appreciated at the genome-scale. Indeed, an autocorrelation analysis unraveled a ~160 113 
bp periodic signal in the genome-wide transposon density (measured using a 40 bp moving average, 114 
Figure 1 – figure supplement 2C). This periodicity was comparable to that of the nucleosomal density 115 
data (Lee et al., 2007). Finally, while no large region was devoid of transposon, some regions were 116 
actually preferentially targeted by transposons. These were the pericentromeric regions (Figure 1B, 117 
top), which were specifically enriched by ~20% of the transposon insertions (Figure 1 – figure 118 
supplement 2D). The explanation for this phenomenon may pertain to nuclear architecture and to the 119 
propensity of our transposon to insert close to its excision site (Lazarow et al., 2012). Because the 120 
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transposon is initially excised from a centromeric plasmid, and because centromeres cluster in the 121 
nuclear periphery (Jin et al., 2000), the transposon might tend to reinsert in the pericentromeric 122 
regions of other chromosomes. We confirmed this assumption by sequencing a small-scale library 123 
(~30 000 insertions mapped) in which the MiniDS transposon was originally at the endogenous ADE2 124 
locus, rather than on a centromeric plasmid. In this library, preferential targeting was not observed at 125 
pericentromeric regions, but rather in the vicinity of ADE2, confirming our assumption (Figure 1B, 126 
bottom).  127 
Identification of essential genes 128 
The transposon map clearly showed that a fraction of the coding DNA sequences (CDS) were devoid of 129 
insertions. These coincided almost exactly with genes annotated as essential (Figure 1C, green 130 
arrowheads). The median number of transposon inserted in the CDSs of all genes was 18 per gene 131 
(Figure 1D). This number raised to 21 for annotated non-essential genes, but dropped to 3 for 132 
annotated essential genes (Figure 1E). This decrease was not due to a difference in the length 133 
between essential and non-essential genes, since normalizing the number of transposon insertions to 134 
the CDS length (transposon density) did not abrogate this effect (Figure 1 – figure supplement 3). 135 
Thus our method distinguishes, in a single step, genes that are required for growth from those that 136 
are not. 137 
Several genes, although annotated as non-essential, harbored no or very few transposons 138 
(Supplementary File 2). This can be attributed to the following reasons. (1) Because sequencing reads 139 
mapping to repeated sequences were discarded during alignment, repeated genes appear as 140 
transposon-free. (2) Several annotated dubious ORFs overlap with essential genes, and thus appear as 141 
transposon-free. (3) Several genes are necessary for growth in particular conditions, and are therefore 142 
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not annotated as essential, yet are required in our growth conditions (SD +galactose -adenine). These 143 
include genes involved, for instance, in galactose metabolism and adenine biosynthesis. 144 
Identification of protein domains 145 
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It came as a surprise that some genes annotated as essential were tolerant to transposon insertion. 146 
While some of these clearly corresponded to annotation inconsistencies, many reflected an 147 
unanticipated outcome of our approach. We observed many instances of "essential" CDSs containing 148 
transposon-permissive regions. A striking example is GAL10 (Figure 2A). GAL10 encodes a bifunctional 149 
enzyme with an N-terminal epimerase, and a C-terminal mutarotase domain (Majumdar et al., 2004). 150 
While the epimerase activity is indispensable in our conditions, the mutarotase activity is dispensable, 151 
as cells were fed a mixture of α- and β-D-Galactose, thus not requiring the conversion of one into the 152 
other. In accordance, the 3’ end of GAL10 was permissive for transposon insertion. The junction 153 
between the permissive and non-permissive domains of GAL10 corresponds exactly to the junction of 154 
the two domains in the Gal10 protein. Several examples of essential genes with dispensable 3’-ends 155 
are shown in Figure 2A. We confirmed the dispensability of the 3' end for two genes, TAF3 and PRP45 156 
(Figure 3).  157 
TAF3 encodes a 47-kDa central component of TFIID (Sanders et al., 2002). Our data show that only the 158 
first 76 amino acids are necessary for growth. Using homologous recombination, we replaced all but 159 
the sequence coding for the first 90 amino acids with an HA tag and a G418-resistance cassette 160 
(KanMX6) in a diploid strain. Sporulation and progeny segregation confirmed that strains expressing 161 
only the first 90 amino acids of Taf3 were viable (Figure 3A). By contrast, complete replacement of 162 
TAF3 gave rise to only two viable, G418-sensitive spores per meiosis, confirming that TAF3 is essential 163 
(Figure 3B). The essential region of Taf3 corresponds to a predicted histone-like bromo-associated 164 
domain (Doerks et al., 2002).  165 
PRP45 encodes a central component of the spliceosome. From our data, only the first 140 amino-acids 166 
of Prp45 are necessary for growth, which we confirmed using the same strategy as for TAF3 (Figure 167 
3C-D). Prp45 is predicted to be intrinsically disordered, thus no clear domain boundaries are available 168 
to rationalize our data. However, a recent cryo-EM structure of the S. cerevisiae spliceosome offers 169 
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clues on the structure of Prp45 (Wan et al., 2016). Prp45 is centrally located within the spliceosome, 170 
has an extended conformation and makes several contacts with various proteins and snRNAs. In 171 
particular, the most conserved region of Prp45 is a loop that makes extensive contacts with U2 and U6 172 
snRNAs close to the active site (Figure 3E-F, yellow). This loop belongs to the dispensable part of 173 
Prp45, surprisingly suggesting that splicing can occur without it. Our method thus offers insights that 174 
neither sequence conservation nor structural analysis could have predicted. 175 
We also observed CDSs in which the 5’ end is permissive for transposon insertion while the 3’ end is 176 
not (Figure 2B-C). Again, our data show a general good coincidence between indispensable regions 177 
and annotated domains. It is surprising that transposons can be tolerated in the 5’ of such genes, 178 
since several stop codons in all frames of the transposon should interrupt translation and prevent the 179 
production of the essential C-terminus. We speculate that the production of the C-terminus is enabled 180 
by spurious transcription events. A remarkable example is SEC9 (Figure 2C). SEC9 encodes a SNARE 181 
protein. The essential SNARE domain, located at the C-terminus (Brennwald et al., 1994), is devoid of 182 
transposons. The N-terminus of the protein is known to be dispensable for growth (Brennwald et al., 183 
1994). We indeed observe several transposons inserted upstream of the SNARE domain. The extreme 184 
5’ of the gene constitutes another transposon-free region even though it encodes a dispensable part 185 
of the protein (Brennwald et al., 1994). It is possible that transposon insertion in this 5’ region 186 
generates an unexpressed, unstable or toxic protein. Other examples of genes showing various 187 
combinations of essential domains are shown in Figure 2C. 188 
We devised an algorithm to score genes according to their likelihood of bearing transposon-tolerant 189 
and -intolerant regions (MatLab Script 2). In short, we computed for each CDS the longest interval 190 
between five adjacent transposons, multiplied it by the total number of transposons mapping in this 191 
CDS, and divided the result by the CDS length. We additionally imposed the following criteria: the 192 
interval must be at least 300 bp, must represent more than 10% and less than 90% of the CDS length, 193 
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and a minimum of 20 transposons must map anywhere within the CDS. ~1200 genes fulfilled these 194 
requirements (Figure 2 – figure supplement 1), of which the 400 best-scoring ones showed clear 195 
domain boundaries (Figure 2 – figure supplement 2-5). Essential subdomains are only expected in 196 
essential genes and indeed, this gene set was overwhelmingly enriched for previously-annotated 197 
essential genes (Figure 2 – figure supplement 1). 198 
Thus, our method allows to identify not only genes, but also subdomains that are important for 199 
growth, yielding valuable structure-function information about their cognate proteins. 200 
Comparison of independent libraries reveals genetic interactions 201 
Our approach can easily identify essential genes and essential protein domains. In addition, its ease 202 
makes it a potential tool to uncover genes that are not essential in standard conditions but become 203 
important in specific conditions. Indeed, our approach yields two measures — the number of 204 
transposons mapping to a given gene, and the corresponding numbers of sequencing reads. Since in 205 
most cases, transposon insertion obliterates the gene function, both measures may be used as a proxy 206 
for fitness. We assessed the usefulness of these metrics in various genetics screens. 207 
Synthetic genetic interaction screening is an extremely powerful approach to establish networks of 208 
functional connections between genes and biological pathways, and to discover new protein 209 
complexes (Costanzo et al., 2010; Schuldiner et al., 2005). We have recently identified single amino-210 
acid substitutions in the endosomal protein Vps13 that suppress the growth defect of mutants of the 211 
ER-mitochondria encounter structure (ERMES) (Lang et al., 2015b). Suppression is dependent on the 212 
proper function of the mitochondrial protein Mcp1 (Tan et al., 2013) and on the endosomal protein 213 
Vam6/Vps39 (Elbaz-Alon et al., 2014; Hönscher et al., 2014). We generated a transposon library from 214 
a strain bearing both the VPS13 suppressor allele VPS13(D716H) and a deletion of the ERMES 215 
component MMM1. In these conditions, we expected VPS13, MCP1 and VAM6/VPS39 to become 216 
 
 
11 
indispensable, while ERMES components (MDM10, MDM12 and MDM34) should become dispensable. 217 
Figure 4A shows, for each of the 6603 yeast CDSs, the number of transposon insertion sites mapped in 218 
the wild-type (x-axis) and in the mmm1Δ VPS13(D716H) library (y-axis). Most CDSs fall on a diagonal, 219 
meaning that they were equally transposon-tolerant in both libraries. Consistent with the ERMES 220 
suppressor phenotype of the VPS13(D716H) mutation, ERMES components fell above the diagonal 221 
(that is, they bore more transposons in the mmm1Δ VPS13(D716H) than in the wild-type library, 222 
Figure 4A-B). By contrast, VPS13, MCP1 and VAM6/VPS39 fell under the diagonal, as expected (Lang 223 
et al., 2015, Figure 4A, C). Many other genes known to display synthetic sick or lethal interaction with 224 
mmm1Δ (Hoppins et al., 2011) were also found, including TOM70, VPS41, YPT7, VMS1 and YME1 225 
(Figure 4A, C).  226 
As a second proof-of-principle, we generated a library from a strain in which the dihydrosphingosine 227 
phosphate lyase gene DPL1 (Saba et al., 1997) was deleted, and another library from a strain in which 228 
both DPL1 and the phosphatidylserine decarboxylase 2 gene PSD2 (Trotter and Voelker, 1995) were 229 
deleted (Figure 4D, F). In this latter double-deleted strain, phosphatidylethanolamine can only be 230 
generated via the mitochondrial phosphatidylserine decarboxylase Psd1, and thus any gene required 231 
for lipid shuttling to and from mitochondria should become indispensable (Birner et al., 2001). 232 
LCB3, which displays synthetic sick interaction with DPL1 (Zhang et al., 2001), was less transposon-233 
tolerant in both the dpl1Δ and the dpl1Δ psd2Δ libraries (Figure 4D). By contrast PSD1, which displays 234 
a synthetic lethality with PSD2 on media lacking choline and ethanolamine (Birner et al., 2001), was 235 
transposon-intolerant in the dpl1Δ psd2Δ library only (Figure 4F-G). Interestingly, we also found that 236 
VPS13 was less transposon-tolerant in the dpl1Δ psd2Δ, consistent with a role for Vps13 in 237 
interorganelle lipid exchange (AhYoung et al., 2015; Kornmann et al., 2009; Lang et al., 2015a, 238 
2015b). 239 
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Additionally, when comparing the dpl1Δ and wild-type libraries, one of the best hits was the histidine 240 
permease HIP1 (Figure 4D-E). This did not, however, reflect a genetic interaction between HIP1 and 241 
DPL1, but instead between HIP1 and HIS3; during the construction of the strains, ADE2 was replaced 242 
by a HIS3 cassette in the wild-type strain, while it was replaced by a NAT cassette in the dpl1Δ strain. 243 
The histidine-auxotroph dpl1Δ strain, therefore required the Hip1 permease to import histidine.  244 
Thus, synthetic genetic interactions are visible through pairwise comparison of the number of 245 
transposons per genes. However, this metrics leads to a significant spread of the diagonal (Figure 4A, 246 
D, F). This spread is due to the intrinsic noise of the experiment. Indeed, the number of transposons 247 
per gene is expected, for each gene, to follow a binomial distribution. Sampling variability may thus 248 
mask biologically relevant differences. To overcome this limitation, we reasoned that comparing sets 249 
of one or more libraries against each other, rather than comparing two libraries in a pairwise fashion 250 
(as in Figure 4), would greatly improve the signal-to-noise ratio. We thus calculated an average fold-251 
change of the number of transposons per gene between the experimental and reference sets, as well 252 
as a p-value (based on a Student’s t-test) associated with this change. The fold-change and p-values 253 
were then plotted as a volcano plot (Figure 4 – figure supplement 1, Supplementary File 3). In volcano 254 
plots, synthetic genes appeared well separated from the bulk of neutral genes, showing that parallel 255 
library comparison is a robust way to increase the signal-to-noise ratio.  256 
Synthetic lethality is one type of genetic interaction. Another type is rescue of lethal phenotype, 257 
where a gene deletion is lethal in an otherwise wild-type strain but can be rescued by a suppressor 258 
mutation. We describe two such phenomena observed in our libraries. The first concerns the septin 259 
gene CDC10. Septin proteins are cytoskeletal GTPases that form a ring at the bud neck. This structure 260 
is necessary for vegetative growth in S. cerevisiae,  and all septin genes are essential with the 261 
exception of CDC10 (Bertin et al., 2008; McMurray et al., 2011). Indeed, at low temperature, cdc10Δ 262 
cells are viable and able to assemble a septin ring. This Cdc10-less ring is based on a Cdc3-Cdc3 263 
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interaction, instead of the normal Cdc3-Cdc10 interaction (McMurray et al., 2011). Because the 264 
propensity of Cdc3 to self-assemble is weak, low temperature is thought to be necessary to stabilize 265 
the interaction. Since we grew all libraries at moderately high temperature (30˚C), CDC10 was, as 266 
expected, essentially transposon-free in most libraries (Figure 5A). In the dpl1Δ psd2Δ library, 267 
however, the number of transposons mapping within CDC10 increased significantly, indicating that 268 
the absence of Psd2 and Dpl1 suppressed the cdc10Δ phenotype (Figure 5A, Figure 4 – figure 269 
supplement 1, bottom left). Genetic analysis revealed that the dpl1Δ allele alone allowed cdc10Δ cells 270 
to grow at higher temperature, indicating that the Cdc10-less septin ring was stabilized in the 271 
absence of Dpl1 (Figure 5B-C). Genetic analysis also demonstrated that the rescue of cdc10Δ by dpl1Δ 272 
was independent of PSD2. It is unclear why the suppressive effect was detected in the dpl1Δ psd2Δ 273 
library, but not in the dpl1Δ library. We speculate that differences in growth conditions between 274 
experiments have obscured either the suppression in the dpl1Δ library or the involvement of Psd2 in 275 
our tetrad analyses. 276 
Dpl1 is an ER protein that does not contact any of the septin subunits; its destabilizing effect on the 277 
septin ring must therefore be indirect. Since Dpl1 is a regulator of sphingolipid precursors (Saba et al., 278 
1997) and since the septin ring assembles in contact with the plasma membrane (Bertin et al., 2010), 279 
it is most likely the changing properties of the membrane in DPL1-deficient cells that allow or restrict 280 
the assembly of Cdc10-less septin rings. This hypothesis is particularly appealing because 281 
temperature has a profound effect on membrane fluidity and composition (Ernst et al., 2016). Thus, 282 
the stabilizing effect of low temperature on Cdc10-less septin rings might not only be the result of a 283 
direct stabilization of Cdc3-Cdc3 interaction, but also of changes in plasma membrane properties, 284 
which can be mimicked by DPL1 ablation.  285 
The second example of rescue of a lethal phenotype was observed in a library made from a strain 286 
expressing a constitutively active version of the Holliday-junction resolvase Yen1, a member of the 287 
 
 
14 
Xeroderma Pigmentosum G (XPG) family of 5’-flap endonucleases (Ip et al., 2008). In wild-type 288 
strains, Yen1 is kept inactive during the S-phase of the cell cycle via Cdk-mediated phosphorylation 289 
(Matos et al., 2011). Rapid dephosphorylation at anaphase activates Yen1 for the last stages of 290 
mitosis. When nine Cdk1 target sites are mutated to alanine, Yen1 becomes refractory to inhibitory 291 
phosphorylation and active during S-phase (Yen1on) (Blanco et al., 2014). To investigate the cellular 292 
consequence of a constitutively active Yen1, we generated a library in a YEN1on background. We 293 
discovered that, under these conditions, the essential gene DNA2 became tolerant to transposon 294 
insertion (Figure 5D). Further genetic analyses confirmed that the presence of the YEN1on allele led to 295 
a rescue of the lethal phenotype of dna2Δ strains; spores bearing the dna2 deletion failed to grow 296 
unless they additionally bore the YEN1on allele (Figure 5E). Moreover, at 25°C, the colony size of 297 
dna2Δ YEN1on spores was comparable to that of the DNA2 counterparts (Figure 5E, right). However, 298 
FACS analysis of DNA content revealed that dna2Δ YEN1on cells accumulated in S- and G2-phases 299 
(Figure 5F). 300 
DNA2 encodes a large protein with both helicase and endonuclease activities (Budd and Campbell, 301 
1995). Interestingly, while the helicase activity can be disrupted without affecting yeast viability, the 302 
nuclease activity is essential (Ölmezer et al., 2016), presumably due to its involvement in processing 303 
long 5’-flaps of Okazaki fragments. Our genetic data now reveal that Yen1 is able to partially fulfill the 304 
essential roles of DNA2, provided that its activity is unrestrained in S-phase. Since the spectrum of 305 
Yen1 substrates includes 5’-flap structures (Ip et al., 2008), Yen1on may be able to substitute the 306 
essential function of Dna2 by providing 5’-flap nuclease activity in S-phase. This finding extends 307 
previous work showing that Yen1 serves as a backup for the resolution of replication intermediates 308 
that arise in helicase-defective mutants of DNA2 (Ölmezer et al., 2016).  309 
Thus, our method can be used to screen for negative and positive genetic interactions in a rapid, 310 
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labor-efficient and genome-wide manner, in strains bearing single and multiple mutations 311 
Chemical Genetics Approach 312 
To assess our method’s ability to uncover drug targets, we used the well-characterized immune-313 
suppressive macrolide rapamycin. Rapamycin blocks cell proliferation by inhibiting the target of 314 
rapamycin complex I (TORC1), through binding to the Fk506-sensitive Proline Rotamase Fpr1 315 
(Heitman et al., 1991). The TORC1 complex integrates nutrient-sensing pathways and regulates 316 
cellular growth accordingly. Rapamycin treatment therefore elicits a starvation response, which stops 317 
proliferation. We generated and harvested a wild-type library, then grew it in medium containing 318 
rapamycin at low concentration. To compare it to an untreated wild-type library, we counted the 319 
number of sequencing reads mapping to each of the 6603 yeast CDSs in both conditions (Figure 6A). 320 
Most genes fell on a diagonal, as they do not influence growth on rapamycin. By contrast, a few genes 321 
were robustly covered by sequencing reads in the rapamycin-treated library, indicating that their 322 
interruption conferred rapamycin resistance. Expectedly, the best hit was FPR1, encoding the receptor 323 
for rapamycin (Hall, 1996). Other hits included RRD1 (Rapamycin-Resistant Deletion 1), TIP41, GLN3, 324 
SAP190, PSP2, CCS1, ESL2 and members of the PP2A phosphatase PPH21 and PPM1 (Figure 6A). These 325 
genes are either directly involved in rapamycin signaling or known to confer rapamycin resistance 326 
upon deletion (Xie et al., 2005).  327 
Finding the TORC1 regulator PIB2 (Kim and Cunningham, 2015) was however unexpected, because 328 
PIB2 deletion confers sensitivity, not resistance, to rapamycin (Kim and Cunningham, 2015; Parsons et 329 
al., 2004). To solve this conundrum, we looked at the distribution of transposons on the PIB2 coding 330 
sequence. All the insertions selected by rapamycin treatment mapped to the 5’-end of the gene 331 
(Figure 6B). On the contrary, the rest of PIB2 was less covered in the rapamycin-treated than in non-332 
rapamycin-treated libraries (Figure 6 – figure supplement 1A). Insertions in the 5’ end of PIB2 333 
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therefore conferred rapamycin resistance, while insertions elsewhere, like complete deletion of PIB2, 334 
conferred rapamycin sensitivity.  335 
To confirm this result, we engineered N-terminal truncations of Pib2, guided by the transposon map. 336 
Strains expressing Pib2 variants that were truncated from the first until up to amino acid 304 were 337 
hyperresistant to rapamycin (Figure 6C, top). We also confirmed that, by contrast, complete PIB2 338 
deletion caused rapamycin hypersensitivity. A larger N-terminal truncation extending beyond the 339 
mapped territory of rapamycin resistance-conferring transposons, did not mediate hyperresistance to 340 
rapamycin (Figure 6G, Pib2426-635).  341 
To assess whether rapamycin-hyperresistant PIB2 truncations  behaved as gain-of-function alleles, 342 
we co-expressed Pib2165-635 and full-length Pib2. In these conditions, the rapamycin hyperresistance 343 
was mitigated, indicating that the effect of the truncated Pib2 protein was semi-dominant (Figure 6C, 344 
bottom). Expressing the truncation from a high-copy (2μ) vector did not further increase resistance to 345 
rapamycin, indicating that higher expression levels did not change the semi-dominance of the PIB2 346 
truncation allele.  347 
Thus, Pib2 truncation leads to a gain-of-function that translates into semi-dominant rapamycin 348 
hyperresistance. Because gain-of-function alleles of PIB2 lead to rapamycin resistance, while loss-of-349 
function alleles lead to sensitivity, our data suggest that Pib2 positively regulates TORC1 function. To 350 
test this idea further, we investigated the effects of full-length and various truncations of Pib2 on 351 
TORC1 signaling. Switching yeast cells from a poor nitrogen source (proline) to a rich one (glutamine) 352 
triggers a fast activation of TORC1 (Stracka et al., 2014), leading to a transient surge in the 353 
phosphorylation of Sch9, a key target of TORC1 in yeast (Urban et al., 2007). We cultured cells on 354 
proline-containing medium and studied TORC1 activation 2 minutes following addition of 3 mM 355 
glutamine by determining the phosphorylation levels of Sch9-Thr737. Pib2 deficiency severely blunted 356 
TORC1 activation in these conditions (Figure 6D, top). In a control experiment, a strain lacking GTR1 – 357 
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a component of the TORC1-activating EGO (Exit from rapamycin-induced GrOwth arrest) complex, 358 
which is orthologous to the mammalian Rag GTPase-Ragulator complex (Chantranupong et al., 2015; 359 
Powis and De Virgilio, 2016) – showed a similarly blunted response with respect to TORC1 activation 360 
following glutamine addition to proline-grown cells (Figure 6D, top). By contrast, glutamine-361 
mediated TORC1 activation appeared normal in a strain expressing an N-terminally truncated Pib2 362 
variant (pPIB2165-635, Figure 6D, bottom). Thus, like Gtr1, Pib2 is necessary to activate TORC1 in 363 
response to amino acids. The N-terminus of Pib2 appears to be an inhibitory domain. The ablation of 364 
this domain confers rapamycin resistance, yet is not sufficient to constitutively activate TORC1 (e.g. in 365 
proline-grown cells).  366 
Having identified an inhibitory activity at the N-terminus of Pib2, we proceeded to address the 367 
function of other Pib2 domains. To this aim, we used a split-ubiquitin-based yeast-two-hybrid assay 368 
to probe the interaction of Pib2 fragments with the TORC1 component Kog1, and studied the 369 
rapamycin resistance of strains expressing various truncations of Pib2 (Figures 6E-F). We found that 370 
Pib2 harbored at least two central Kog1-binding regions, since two mostly non-overlapping 371 
fragments (Pib21-312 and Pib2304-635) showed robust interaction with Kog1 (Figure 6F and Figure 6 – 372 
figure supplement 1B). Kog1 binding is, however, not essential for Pib2-mediated TORC1 activation, 373 
since cells expressing a fragment without these Kog1-binding domains (Pib2426-635) were as 374 
rapamycin-resistant as cells expressing full length Pib2 (FL, Figure 6G).  375 
Pib2 harbors a phosphatidylinositol-3-phosphate (PI3P) -binding Fab1-YOTB-Vac1-EEA1 (FYVE) 376 
domain (Figure 6E). Pib2 truncations lacking the FYVE domain are unable to bind PI3P, and hence to 377 
properly localize to the vacuole (Kim and Cunningham, 2015). When cells expressed FYVE domain-378 
truncated Pib2 (Pib2Δ426-532), their rapamycin resistance decreased, but not as severely as observed in 379 
pib2Δ strains (Figure 6G). This indicates that FYVE-domain-mediated vacuolar recruitment is not 380 
absolutely required for Pib2 to activate TORC1. 381 
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Strikingly, cells expressing Pib2 variants that were either truncated at the extreme C-terminus (PIB21-382 
620) or carried a deletion within the C-terminus (PIB2Δ533-620) were as sensitive to rapamycin as pib2Δ 383 
cells (Figure 6G). The C-terminus of Pib2 is therefore important to ensure proper TORC1 activation. 384 
We conclude that Pib2 harbors the following functional domains: a large N-terminal Inhibitory 385 
Domain (NID), and a C-terminal TORC1-Activating Domain (CAD); the central portion of the protein 386 
harbors FYVE and Kog1-binding domains for proper targeting of Pib2 to the vacuole and TORC1, 387 
respectively.  388 
Could the NID act in an auto-inhibitory allosteric fashion by preventing the CAD from activating 389 
TORC1? We reasoned that if this were the case, plasmid-encoded N-terminally truncated Pib2 should 390 
confer similar levels of rapamycin resistance independently of whether a genomic wild-type PIB2 391 
copy was present or not. However, wild-type cells expressing N-terminally truncated Pib2165-635 from a 392 
centromeric or a multi copy 2μ plasmid were less resistant to rapamycin than pib2Δ cells expressing 393 
Pib2165-635 from a centromeric plasmid (Figure 6C). Thus, the NID activity of the endogenously-394 
expressed wild-type Pib2 is able to mitigate the rapamycin resistance conferred by ectopic expression 395 
(or overexpression) of the CAD. Therefore, our data suggest that the NID does not auto-inhibit the CAD 396 
within Pib2, but rather, that the NID and CAD act independently and antagonistically on TORC1.  397 
This latter scenario predicts that, just as expressing NID-truncated Pib2 semi-dominantly activates 398 
TORC1 (Figure 6C), expressing CAD-truncated Pib2 should semi-dominantly inhibit it. To test this 399 
prediction, we expressed the two CAD truncations Pib2Δ533-620 and Pib21-620 in an otherwise wild-type 400 
strain. The resulting strains were significantly more sensitive to rapamycin than their counterparts 401 
expressing only full length Pib2 (Figure 6H). Furthermore, when pib2Δ cells expressed the Pib2 CAD 402 
truncation alleles, they became even more sensitive to rapamycin. Therefore, Pib2-NID does not act in 403 
an auto-inhibitory manner, but rather inhibits TORC1 independently of the presence of a Pib2-CAD. 404 
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Since the Rag GTPase Gtr1-Gtr2 module of the EGO complex also mediates amino acid signals to 405 
TORC1 (Binda et al., 2009; Dubouloz et al., 2005, see also Figure 6D), we tested the possibility that 406 
Pib2-NID inhibits TORC1 by antagonizing Gtr1-Gtr2. This does not appear to be the case; first, the 407 
expression of Pib2Δ533-620 or Pib21-620 further enhanced the rapamycin sensitivity of gtr1Δ gtr2Δ cells 408 
(Figure 6 – figure supplement 1C), and second, the Pib2Δ533-620- or Pib21-620–mediated rapamycin 409 
hypersensitivity was not suppressed by expression of the constitutively active, TORC1-activating 410 
Gtr1Q65L-Gtr2S23L module (Binda et al., 2009; Figure 6 – figure supplement 1D). These results suggest 411 
that Pib2-NID inhibits TORC1 independently of the EGO complex.  412 
In summary, Pib2 is targeted to TORC1 by binding to the vacuolar membrane through its FYVE domain 413 
and to Kog1 via its middle portion. Pib2 harbors two antagonistic activities, one activating and the 414 
other repressing TORC1. The dose-independent semi-dominant nature of the respective truncations 415 
indicate that both repressing and activating activities influence TORC1 independently and do not 416 
appear to compete for the same sites on TORC1.  417 
We speculate that high-quality amino acids, such as glutamine, balance the antagonistic TORC1-418 
activating and -repressing activities of Pib2 to tune growth rate according to available resources. In 419 
this context, it will be interesting to elucidate how the activities of Pib2 and the EGO complex are 420 
coordinated to stimulate TORC1 in response to amino acids. 421 
Discussion 422 
Here we present a novel method based on random transposon insertion and next-generation 423 
sequencing, to functionally screen the genome of Saccharomyces cerevisiae. SAturated Transposon 424 
Analysis in Yeast (SATAY) can reveal positive and negative genetic interactions, auxotrophies, drug-425 
sensitive or -resistant mutants, and map functional protein domains. SATAY combines advantages 426 
from both classical genetics and high-throughput robotic screens. SATAY can in principle be 427 
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implemented in any strain background, since it does not rely on the existence of available deletion 428 
libraries and does not necessitate markers to follow genetic traits. Moreover, SATAY explores a wide 429 
genetic space; exotic alleles can be generated as exemplified by PIB2 (Figure 6 and Figure 6 – figure 430 
supplement 1), where transposon insertions in different regions of the gene generate opposite 431 
phenotypes. Transposon insertion is not limited to CDSs; we observe that promoters of essential genes 432 
are often transposon-intolerant (Figure 2, see GAL10, SGV1, MMS21, RET2, HRR25, NPA3, SEC9, SWI1). 433 
We also observe that known essential tRNA, snRNA, as well as SRP RNA genes are transposon 434 
intolerant (see Supplementary Dataset). Finally, our data reveal transposon-intolerant areas of the 435 
genome that do not correspond to any annotated feature, indicating that SATAY could help discover 436 
yet-unknown functional elements. 437 
SATAY yields unprecedented insight on the domain structure- function relationship of important 438 
proteins, and allows the mapping of important functional domains, without prior knowledge. 439 
Dispensable domains in essential proteins might not be required for the essential function of these 440 
proteins, but may have other roles. The sub-gene resolution enabled by SATAY may thus unveil yet-441 
unsuspected accessory or regulatory functions, even in otherwise well-studied proteins. In addition, 442 
structure-function information revealed by SATAY may guide 3D-structure determination efforts by 443 
indicating possibly flexible accessory domains. 444 
The resolution of a SATAY screen is directly proportional to the number of transposons mapped onto 445 
the genome. The current resolution is ~1/40 bp, which is amply sufficient to confidently identify 446 
essential genes and protein domains. This resolution is achieved by mapping ~300,000 transposons, 447 
starting from a 1.6E6-colonies library. Not every colony generates a detectable transposon. This is due 448 
to several reasons. (1) Excised transposons only reinsert in 60% of the cases (our observations and 449 
Lazarow et al., 2012). (2) 7% of the sequencing reads mapped onto repetitive DNA elements (such as 450 
rDNA, Ty-elements and subtelomeric repeats) and were discarded because of ambiguous mapping. 451 
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(3) Two transposons inserted in the same orientation within two bp of each other will be considered 452 
as one by our algorithm. This might be exacerbated at densely covered areas of the genome, such as 453 
pericentromeric regions. (4) Some transposon insertion products may not be readily amplifiable by 454 
our PCR approach. 455 
We observe that increasing both the size of the original library and the sequencing depth leads to an 456 
increase in mapped transposon number (albeit non-proportional, Table 1). Therefore, the resolution 457 
of a screen can be tailored according to the question and the available resource.  458 
We could not detect a preferred sequence for transposon insertion (Figure 1 -figure supplement 2A), 459 
yet two features of the yeast genome biased insertion frequency in select regions. The first is 460 
nucleosome position; the Ac/Ds transposon has a tendency to insert more frequently within inter-461 
nucleosomal regions, indicating that the transposase might have better access to naked DNA (Figure 1 462 
-figure supplement 2B-C). The second pertains to a tendency of the transposon to integrate in the 463 
spatial proximity of its original location (Lazarow et al., 2012). Indeed, when originated from a 464 
centromeric plasmid, the transposon has an increased propensity to reinsert in the pericentromeric 465 
regions of other chromosomes. This is not due to a particular feature of pericentromeric chromatin, 466 
since this propensity is lost when the transposon original location is on the long arm of ChrXV (Figure 467 
1B). Instead, the increased propensity is likely resulting from the clustering of centromeres in the 468 
nuclear space (Jin et al., 2000), indicating that centromeric plasmids cluster with the chromosomal 469 
centromeres. Thus, SATAY can be utilized to probe, not only the function of the genome, but also its 470 
physical and regulatory features, such as nucleosome position and 3D architecture. 471 
Finally, SATAY does not require any particular equipment besides access to a sequencing platform, 472 
and involves a limited amount of work. It can be easily multiplexed to perform several genome-wide 473 
screens simultaneously. Each screen yields two measures, the number of transposons and the number 474 
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of sequencing reads, both of which, for each gene, reveal the fitness of the cognate mutant. While the 475 
number of transposons per gene is appropriate to look for genes that become important for growth, 476 
as in genetic interaction screens, the number of sequencing reads is better suited to identify strains 477 
that are positively selected, like drug-resistant mutants. Both metrics suffer from intrinsic noise, 478 
stemming from the inherently discrete structure of the data, and probably also from unavoidable 479 
biases in the amplification and sequencing of the libraries. We show that this noise can be reduced by 480 
comparing multiple libraries against each other (Figure 4 – figure supplement 1). Moreover, 481 
comparing multiple libraries allows to tailor the composition of each library set to needs. For instance, 482 
grouping the VPS13(D716H) with the mmm1Δ VPS13(D716H) libraries allows to selectively detect 483 
synthetic interactions with VPS13(D716H) (e.g. ERMES components). By contrast, comparing the 484 
mmm1Δ VPS13(D716H) library with all others, selectively finds genes important for the ERMES 485 
suppression phenomenon. Thus, while signal-to-noise ratio might be a limiting factor for the 486 
detection of genetic interactions, we anticipate that increasing the number of libraries, for instance by 487 
generating multiple libraries in each conditions, will likely decrease the incidence of false positive and 488 
false negative. With the increasing number of screens performed in various conditions will also come 489 
the ability to find correlation patterns among genes that are required or dispensable for growth in 490 
similar sets of conditions. Such correlations are accurate predictors of common functions and have 491 
been extensively used in synthetic genetic screens, such as the E-MAP procedure (Kornmann et al., 492 
2009; Schuldiner et al., 2005). However, while E-MAP screens compute patterns of genetic interaction 493 
on a subset of chosen genetic interaction partners, SATAY allows to detect genetic interactions at the 494 
genome scale. 495 
Because SATAY only necessitates a transposon and a transposase, it should be portable to other 496 
industrially-, medically- or scientifically-relevant haploid fungi, such as S. pombe, Y. lipolytica, C. 497 
glabrata, K. lactis and P. pastoris. 498 
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The Ds transposon can in principle accommodate extra sequences with no known length limitation 499 
(Lazarow et al., 2013). An interesting future development will be to incorporate functional units in 500 
the transposon DNA, for instance strong promoters, repressors or terminators, IRESs, recognition sites 501 
for DNA-binding proteins (LacI or TetR), recombination sites (LoxP, FRP), or coding sequences for in-502 
frame fusion, such as GFP, protein- or membrane-binding domains, signal sequences, etc. Improved 503 
designs will not only permit finer mapping of protein domains without reliance on spurious 504 
transcription and translation, but might allow the exploration of an even wider genetic space, for 505 
instance by generating gain-of-function variants, thus enabling the development of novel approaches 506 
to interrogate the yeast genome. 507 
Methods 508 
Plasmids and strains 509 
 510 
All Yeast strains, oligonucleotides and plasmids used herein are listed in Tables 2, 3 and 4, 511 
respectively. To generate pBK257, the ADE2 gene interrupted with the MiniDs transposon was PCR 512 
amplified from strain CWY1 (Weil and Kunze, 2000), using PCR primers #4 and #5. The PCR product 513 
and pWL80R_4x (plasmid encoding the Ac transposase under the control of the GAL1 promoter, 514 
Lazarow et al., 2012) were digested with SacI, then ligated together. This plasmid does not confer 515 
Adenine prototrophy to ade2Δ cells unless the Ac transposase excises the MiniDS transposon, and 516 
repairs the ADE2 gene. 517 
Deletion strains were generated by PCR-mediated gene replacement using the Longtine toolbox for 518 
KanMX6 and HIS3 replacement (Longtine et al., 1998) and the Janke toolbox for NATnt2 (Janke et al., 519 
2004), with primers listed in Table 3. Strain YJM3916 carrying YEN1ON at the endogenous locus was 520 
generated using the delitto perfetto method (Storici and Resnick, 2003). 521 
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Library generation 522 
ade2Δ strains were transformed with the pBK257 plasmid. These strains are phenotypically ade-, 523 
since the ADE2 gene borne on the plasmid is interrupted by the MiniDs transposon. One liter of freshly 524 
prepared SD -Ura +2% Raffinose + 0.2% Dextrose is inoculated with ade2Δ cells freshly transformed 525 
with pBK257, directly scraped off the transformation plates, at a final OD600=0.15. The culture is 526 
grown to saturation for 18 to 24hr at 30°C. Cells are spun for 5min at 600x g, 20°C) and resuspended 527 
in their supernatant at a final OD600=39. 200 μl of this resuspension are plated on ~250-300 X 8.5cm 528 
plates containing 25 ml of SD +2%Galactose -Adenine using glass beads. Plates are incubated in 529 
closed but not sealed plastic bags for 3 weeks at 30°C. Clones in which transposon excision has led to 530 
the repair of the ADE2 gene on pBK257 start to appear after 10-12 days. The density of clones on the 531 
plate reaches 150-200 colonies/cm2, i.e. 8000-11000 colonies/plates after 3 weeks. All colonies are 532 
then scraped off the plates using minimal volume of either water or SD +2% Dextrose -Adenine, 533 
pooled, and used to inoculate a 2-liter SD +2% Dextrose -Adenine culture at a density of 2.5 106 534 
cells/ml, which is allowed to grow to saturation. This step is used to dilute any remaining ade- cells, 535 
which represent about 20% of the total number of cells, and ensures that each transposition event is 536 
well represented. For example, reseeding a 2.106 clones library in 2L at a density of 2.5 106 cells/ml 537 
will ensure that each clone is represented by ((2.500.000X1000X2)*0.8)/2.000.000= 2000 cells. The 538 
saturated culture is harvested by centrifugation (5 min, 1600x g), washed with ddH2O, then cell 539 
pellets are frozen as ~500 mg aliquots. 540 
Rapamycin treatment 541 
Cells scraped off the plates were used to inoculate a 1 liter SD +2% Dextrose -Adenine culture at OD 542 
0.08. After growing for 15 h to OD 0.5, the culture was diluted to OD 0.1 in 500 ml SD +2% Dextrose -543 
Adenine, treated with 10 nM (9.14 ng/ml) rapamycin (Sigma) and grown for 24 h to OD 0.9. The 544 
culture was then diluted again to OD 0.1 in 500 ml SD +2% Dextrose -Adenine +10 nM rapamycin. 545 
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The treated culture was grown to saturation (OD 1.9), harvested by centrifugation and processed for 546 
genomic DNA extraction. 547 
Genomic DNA 548 
A 500-mg cell pellet is resuspended with 500 μl Cell Breaking Buffer (2% Triton X-100, 1% SDS, 100 549 
mM NaCl, 100 mM Tris-HCl pH8.0, 1 mM EDTA) and distributed in 280μl aliquots. 200 μl 550 
Phenol:Chloroform:Isoamylalcool 25:25:1 and 300 μl 0.4-0.6mm unwashed glass beads are added to 551 
each aliquot. Samples are vortexed for 10 min at 4°C using a Disruptor Genie from Scientific Industrial 552 
(US Patent 5,707,861). 200 μl TE are added to each lysate, which are then centrifuged for 5 min at 553 
16100x g, 4°C. The upper layer (~400 μl) is transferred to a fresh tube, 2.5vol 100% EtOH are added 554 
and the sample mixed by inversion. DNA is pelleted for 5 min at 16100x g, 20°C. The supernatant is 555 
removed and the pellets resuspended in 200 μl RNAse A 250 μg/ml for 15 min at 55°C, 1000 rpm on a 556 
Thermomixer comfort (Eppendorf). 2.5 vol 100% EtOH and 0.1vol NaOAc 3 M pH5.2 are added and the 557 
samples mixed by inversion. DNA is pelleted by centrifugation for 5 min at 16100x g, 20°C. The pellets 558 
are washed with 70% EtOH under the same conditions, the supernatant removed completely, and the 559 
pellets dried for 10 min at 37°C. The pellets are resuspended in a total volume of 100 μl water for 10 560 
min at 55°C, 700 rpm on a Thermomixer comfort (Eppendorf). 561 
DNA is run on a 0.6% 1X TBE agarose gel against a standard 1 kb GeneRuler, and quantified using FiJi. 562 
500 mg cell pellet should yield  20-60 μg DNA. 563 
Library Sequencing 564 
Sequencing involves the following steps: (1) Digestion of genomic DNA with two four-cutter 565 
restriction enzymes, (2) ligase-mediated circularization of the DNA, (3) PCR of the transposon-566 
genome junctions using outward-facing primers. (4) Illumina-sequencing of the combined PCR 567 
products. 568 
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2x 2 μg of genomic DNA are digested in parallel in Non-Stick microfuge tubes (Ambion AM12450) 569 
with 50 units of DpnII (NEB #R0543L) and NlaIII (NEB #R0125L), in 50 μl for 16 hours at 37°C. The 570 
reactions are then heat inactivated at 65°C for 20 min and circularized in the same tube by ligation 571 
with 25 Weiss units T4 Ligase (Thermo Scientific #EL0011) for 6 hours at 22°C, in a volume of 400μl. 572 
DNA is precipitated overnight or longer at -20°C in 0.3 M NaOAc pH5.2, 1 ml 100% EtOH, using 5 μg 573 
linear acrylamide (Ambion AM9520) as a carrier, then centrifuged for 20 min at 16100x g, 4°C. Pellets 574 
are washed with 1 ml 70% EtOH, for 20 min at 16100 x g, 20°C. After complete removal of the 575 
supernatant, pellets are dried for 10 min at 37°C. Each circularized DNA preparation is then 576 
resuspended in water and divided into 10X 100 μl PCR reactions. Each 100 μl PCR reaction contains: 10 577 
μl 10X Taq Buffer (500 mM Tris-HCl pH9.2, 22.5 mM MgCl2, 160 mM NH4SO4, 20% DMSO, 1% Triton 578 
X-100 – stored at -20°C), 200 μM dNTPs, 1 μM primer #1, 1 μM primer #2 , 2.4 μl homemade Taq 579 
polymerase. PCR are performed in an MJ Research Peltier Thermal Cycler PTC-200 using the following 580 
conditions: 581 
Block: calculated – 95°C 1 min, 35X [95°C 30 sec, 55°C 30 sec, 72°C 3 min], 72°C 10 min. 582 
The 2X 10 PCR reactions are pooled into one NlaIII-digested pool and one DpnII-digested pool. 100μl 583 
from each pool are purified using a PCR clean-up/gel extraction kit (Macherey-Nagel) according to the 584 
manufacturer protocol, with the following modifications. DNA is bound to the column for 30s at 585 
3000x g; 30 μl of elution buffer (10 mM Tris-HCl pH8.5, 0.1% Tween) is applied to the column and 586 
incubated for 3 min, then spun for 1 min at 11000x g at 20°C. The eluate is reapplied to the column 587 
and a second elution is performed under the same conditions. Purified PCR products are quantified by 588 
absorbance at 260 nm. On a 1% agarose gel, the product runs as a smear from 250 bp to 1.2 kb, with 589 
highest density centered around 500 bp. The 867 bp size band present in the NlaIII treated sample 590 
and the 465 bp size band present in the DpnII treated sample correspond to untransposed pBK257. 591 
Equal amounts of DpnII- and NlaIII-digested DNA are pooled and sequenced using MiSeq v3 592 
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chemistry, according to manufacturer, adding 3.4 μl of 100 μM primer #3 into well 12 of the 593 
sequencing cartridge. 594 
Bioinformatics Analyses 595 
The fastq file generated is uploaded into the CLC genomics workbench, trimmed using adaptor 596 
sequences ‘GATC’ and ‘TAGC’ (the recognition sites for NlaIII and DpnII, respectively), allowing 2 597 
ambiguities and a quality limit of 0.05. The trimmed sequence is then aligned to the reference 598 
genome, using the following parameters (mismatch cost, 2; Insertion and deletion costs, 3; length 599 
fraction, 1; similarity fraction, 0.95; non-specific match handling, ignore). The alignment is then 600 
exported as a BAM file, which is further processed in MatLab, using the MatLab Script 1, to detect 601 
individual transposition events. The outputted bed file is uploaded to the UCSC genome browser. 602 
Yeast annotations were downloaded from the Saccharomyces Genome Database (SGD). To generate 603 
our list of essential genes, we used YeastMine and searched the SGD for genes for which the null 604 
mutant has an “inviable” phenotype (Balakrishnan et al., 2012). 605 
Volcano plots were computed as follows using MatLab Script 3. Two sets of libraries were defined. For 606 
each gene and each library, the number of transposons per gene (tnpergene variable) was normalized 607 
to the total number of transposon mapped in the library. For each gene, the fold-change is calculated 608 
as the mean of the normalized number of transposons per gene in the experimental set, divided by 609 
that in the reference set. The p-value is computed using the Student’s t-test by comparing, for each 610 
gene, the normalized number of transposons per gene for each library in the experimental and 611 
reference sets. 612 
Western blotting 613 
Cells were grown to mid-log phase in synthetic minimal medium containing 0.5 g/L proline as a sole 614 
nitrogen source and stimulated with 3 mM glutamine for 2 minutes. Cells were treated with 6.7% 615 
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w/v trichloroacetic acid (final concentration), pelleted, washed with 70% ethanol and then lyzed in 616 
urea buffer (50 mM Tris-HCl [pH 7.5], 5 mM EDTA, 6 M urea, 1% SDS, 0.1 mg/ml 617 
Pefabloc/phosphatase inhibitor mix). After disrupting cells with glass beads and incubating with 618 
Laemmli SDS sample buffer, samples were subjected to regular SDS-PAGE and immunoblotting. The 619 
phosphorylation level of Sch9-Thr737 and the total amount of Sch9 were assessed using the 620 
phosphospecific anti-Sch9-pThr737 and anti-Sch9 antibodies, respectively (Péli-Gulli et al., 2015). 621 
Split-ubiquitin yeast two-hybrid assay 622 
The split-ubiquitin yeast two-hybrid system from Dualsystems Biotech AG was used following the 623 
manufacturer’s instructions. 624 
Pib2 fragments (full-length or truncated) and full-length Kog1 were cloned into pCabWT and pPR3N 625 
plasmids, respectively, and transformed into the strain NMY51 as indicated. Protein-protein 626 
interactions were detected as growth of the resultant strains on agar plates lacking adenine.  627 
Accession Numbers 628 
Sequencing data have been deposited at EMBL-EBI ArrayExpress: E-MTAB-4885. 629 
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Figure legends 754 
Figure 1 755 
Principle of the method. 756 
A) Outline of the experimental procedure. Left, the transposon (green) can insert either into non-757 
essential DNA (blue) and give rise to a clone, or into essential DNA (orange), in which case no clone is 758 
formed. Right, procedure to identify transposon insertion sites by deep-sequencing. 759 
B) Profile of the transposon density across the whole genome, when the transposon original 760 
location is either a centromeric plasmid (top) or the endogenous ADE2 locus on chromosome XV 761 
(bottom). The dashed lines indicate the chromosome centromeres. 762 
C) Six examples of genomic regions and their corresponding transposon coverage in seven 763 
independent transposon libraries of indicated genotypes. Each vertical grey line represents one 764 
transposon insertion event. Genes annotated as essential are shown in orange, others in blue. Green 765 
arrowheads indicate the places where the absence of transposon coverage coincides with an essential 766 
gene. 767 
D) Histogram of the number of transposons found in every annotated gene (CDS). The vertical 768 
dashed line is the median of the distribution. 769 
E) Same as D, with genes categorized as non-essential (blue) and essential (orange) according to 770 
previous annotations. 771 
Figure 1 – figure supplement 1 772 
Size distribution of the colonies appearing on SD +Galactose -Ade. A) Histogram of colony area for a 773 
randomly chosen sample of 402 colonies. B) Example of picture of colonies (top) and segmentation 774 
thereof (bottom) used to calculate histogram in (A). Scale bar, 1 mm 775 
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Figure 1 - figure supplement 2  776 
Genome-wide analysis of transposon insertion sites. A) Frequency plot of nucleotide composition 777 
around transposon insertion site. The strand is determined according to the orientation of the 778 
transposon insertion. Plot was calculated with a random sample of 50,000 transposon in the wild-779 
type library 1. Note that GC-content of the yeast genome is 38%. B) Preferential transposon insertion 780 
into internucleosomal DNA. Three genomic regions are shown. For each, the top panel shows the 781 
nucleosomal density as determined in (Lee et al., 2007), and the bottom panels shows transposon 782 
insertion as in Figures 2-5. C) Correlation analysis of nucleosome and transposon density. Transposon 783 
densities were calculated on the wild-type library 1 by averaging transposon number within a 40 bp 784 
moving average. Top, correlation coefficient calculated between the nucleosome and the transposon 785 
data offset by the indicated number of bp. The correlation is most negative when offset=0. The 786 
periodicity is ~160 bp. Middle, autocorrelation of transposon data. The periodicity is identical as 787 
above. Bottom, autocorrelation of the nucleosome density data. The periodicity is identical as above. 788 
D) Analysis of transposon number relative to distance from centromere. For each chromosome, the 789 
number of transposons mapping within a certain distance from their respective centromere was 790 
computed and plotted (grey lines). The number of transposons increases linearly with the distance, 791 
except in the vicinity of the centromere, where transposon enrichment can be observed. The intercept 792 
of the linear regression, computed on the linear part of the plot and multiplied by 16 chromosomes, 793 
gives a rough estimate of the numbers of transposons enriched at pericentromeric regions (~20% of 794 
the total transposon number). 795 
Figure 1 - figure supplement 3  796 
Transposon density in essential and non-essential genes. As in Figure 1D-E, except that, for each 797 
gene, the transposon density (i.e. number of transposons divided by length of the gene) is shown.  798 
Figure 2 799 
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Examples of genes showing partial loss of transposon coverage. The grey level is proportional to the 800 
number of sequencing reads. Known functional domains are indicated. 801 
A) Essential genes for which C-terminal truncations yield a viable phenotype. 802 
B) Essential genes for which N-terminal truncations yield a viable phenotype. 803 
C) Essential genes for which various truncations yield a viable phenotype. 804 
Figure 2 - figure supplement 1  805 
Detection of essential protein domains. Top, algorithm to detect essential protein domains. 806 
This algorithm is implemented in MatLab Script 2. For each gene, a score is computed as 807 
follows: the longest interval between transposon n and transposon n+5, multiplied by the 808 
total number of transposons mapping to that gene, divided by the gene length to the 809 
power of 1.5. A score of 0 is assigned to genes targeted by less than 20 transposons, in 810 
which the longest interval is smaller than 300 bp, and/or in which the longest interval 811 
represents more than 90% or less than 10% of the CDS length. Bottom, yeast genes sorted 812 
according to their domain likelihood score. Vertical black bars above the graph indicate 813 
previously annotated essential genes. 814 
Figure 2 - figure supplement 2  815 
Transposon maps in the 100 highest scoring genes. Grey scale indicates the number of 816 
sequencing reads as in Figure 2.  817 
Figure 2 - figure supplement 3  818 
 Transposon maps in the genes scoring 101 to 200. 819 
Figure 2 - figure supplement 4 820 
Transposon maps in the genes scoring 201 to 300. 821 
Figure 2 - figure supplement 5 822 
Transposon maps in the genes scoring 301 to 400. 823 
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Figure 3 824 
TAF3 and PRP45 can be truncated without visible effects on cell growth. 825 
A) A truncation of TAF3 was generated in a heterozygous diploid strain (left) by introduction of an HA 826 
tag and a G418-resistance cassette (HA kanr). The strain was tetrad dissected (middle). Tetrads 2 and 827 
3 were further analyzed by PCR to confirm the mendelian segregation of the truncated allele (right). 828 
B) A complete TAF3 deletion was generated in a heterozygous diploid strain (left) by introduction of a 829 
G418-resistance cassette (kanr). Meiosis yields only two viable, G418-sensitive spores per tetrad, 830 
confirming that TAF3 complete deletion is lethal. 831 
C-D) As in (A-B) but applied to PRP45. Asterisks in the right panel designate PCR reactions that were 832 
inefficient at amplifying the large truncated allele. The genotype of these spores can nevertheless be 833 
inferred from the mendelian segregation of the G418 resistance.  834 
E) Top, cryo-EM structure of the S. cerevisiae spliceosome (PDB accession 5GMK (Wan et al., 2016)). 835 
Bottom, the same structure stripped of every protein except Prp45. The essential portion of Prp45 as 836 
defined in (C) is in green and the non-essential part is in red and yellow. U2, U6, U5 and substrate 837 
RNAs are depicted in pale blue, pink, dark blue and orange, respectively. The red circle indicates the 838 
catalytic active site of the spliceosome. 839 
F) Alignment of the Human, S. cerevisiae, and S. pombe Prp45 orthologs. The green, red and yellow boxes 840 
are colored as in (E). The yellow box features the most conserved region of the protein. 841 
Figure 4 842 
Genetic interaction analyses. Libraries in panels B, C, E and G are displayed in the same order as in 843 
Figure 1C. 844 
A) Comparison of the number of transposons inserted in each of the 6603 yeast CDSs in the wild-type (x-845 
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axis) and mmm1Δ VPS13(D716H) (y-axis) libraries. 846 
B) Transposon coverage of genes encoding ERMES components is increased in libraries from strains 847 
bearing the VPS13(D716H) allele.  848 
C) Examples of genes showing synthetic sick/lethal interaction with mmm1Δ VPS13(D716H). 849 
D) Comparison of the number of transposons inserted in each of the 6603 yeast CDSs in the wild-type 850 
(x-axis) and dpl1Δ (y-axis) libraries. 851 
E) Transposon coverage of the HIP1 locus in the dpl1Δ his3Δ library and in all the other libraries (HIS3). 852 
F) Comparison of the number of transposons inserted in each of the 6603 yeast CDSs in the dpl1Δ (x-853 
axis) and dpl1Δ psd2Δ (y-axis) libraries. 854 
G) Transposon coverage of the PSD1 locus in the dpl1Δ psd2Δ and in all other libraries. 855 
Figure 4 – figure supplement 1 856 
Volcano plots comparing libraries or combinations of libraries as indicated. The calculated fold-change 857 
in transposon density between the two sets of libraries is plotted in log2 scale on the x-axis. The -858 
log10(p-value) (computed using the Student’s t-test) is plotted on the y-axis. (1)The VPS13(D716H) and 859 
the mmm1Δ VPS13(D716H) strains were generated in a MET17 background while all other libraries 860 
where generated in a met17Δ background. As a result MET17 and the overlapping ORF YLR302C 861 
appear as transposon free in the reference set. MET6 is more targeted by transposons in met17Δ 862 
libraries, likely because Met17 produces homocysteine, which needs to be converted to methionine by 863 
Met6, or might otherwise accumulate to toxic levels. (2)The VPS13(D716H) and mmm1Δ 864 
VPS13(D716H) strains were generated in a Matα background, while the others were generated in a 865 
Mata background. (3)YGR190C overlaps with HIP1. (4)GPP1 shows synthetic lethality with a recessive 866 
mendelian variant present in the psd2Δ dpl1Δ strain. However, this variant is neither linked to DPL1 867 
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nor to PSD2 (data not shown). (5)ERMES component genes scores very high with respect to fold 868 
change, because two of the five libraries in the reference set bear the VPS13(D716H) allele. The p-869 
value, by contrast, is not significant. 870 
Figure 5 871 
Synthetic rescue of lethal phenotypes 872 
A) Transposon coverage of CDC10 in the seven libraries. The coverage is increased in the dpl1Δ psd2Δ 873 
library.  874 
B) Tetrad dissection of a PSD2/psd2Δ DPL1/dpl1Δ CDC10/cdc10Δ triple heterozygote at 30°C (left) and 875 
25°C (right). The cdc10Δ spores of ascertained genotype are circled with a color-coded solid line. 876 
cdc10Δ spores for which the genotype can be inferred from the other spores of the tetrad are circled 877 
with a color-coded dashed line. 878 
C) Quantification of growing and non-growing cdc10Δ spores of the indicated genotype obtained 879 
from 48 tetrads (three independent diploids). 880 
D) Transposon coverage of DNA2 in the seven libraries. The coverage is increased in the YEN1on library. 881 
E) Tetrad dissection of a DNA2/dna2Δ YEN1/YEN1 single heterozygote and of a DNA2/dna2Δ 882 
YEN1/YEN1on double heterozygote at 30°C (left) and 25°C (right). All viable dna2Δ spores additionally 883 
carry the YEN1on allele (red circle). 884 
F) FACS profile of propidium-iodide-stained DNA content in DNA2 and dna2Δ YEN1on strains 885 
exponentially growing at 30°C (left) and 25°C (right). For DNA2 panels, each profile is an overlay of 886 
two independent strains. For dna2Δ YEN1on panels, each profile is an overlay of four independent 887 
strains. 888 
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Figure 6 889 
Detection of rapamycin resistant strains. 890 
A) Comparison of the number of sequencing reads mapping to each of the 6603 yeast CDSs in 891 
rapamycin-untreated (x-axis) and -treated (y-axis) libraries. Note the difference in scale between 892 
both axis due to the high representation of rapamycin-resistant clones. 893 
B) Distribution of transposons and number of associated sequencing reads on the PIB2 gene. 894 
Transposons with high number of sequencing reads in the rapamycin-treated library are clustered at 895 
the 5’-end of the CDS. 896 
C) Wild-type (WT) and pib2Δ strains were transformed with either an empty plasmid () or plasmids 897 
encoding full-length (FL) or indicated fragments of Pib2 (see E, numbers refer to the amino acid 898 
position in the full-length Pib2 protein). 5-fold serial dilutions of these strains were spotted on YPD 899 
or YPD containing 10 ng/ml rapamycin. Centromeric plasmids were used in all strains, except in 900 
those denoted with 2μ, which carried multi-copy plasmids. 901 
D) Strains of the indicated genotypes, transformed with either an empty plasmid () or plasmids 902 
encoding full length (pPIB2) or truncated (pPIB2165-635) versions of Pib2, were grown exponentially in 903 
minimal medium with proline as nitrogen source. 3 mM glutamine was added to the culture and the 904 
cells were harvested 2 minutes later. Protein extracts were resolved on an SDS-page and probed 905 
with antibodies either specific for Sch9-pThr737 (P-Sch9), or for total Sch9 to assess TORC1 activity. 906 
E) Schematic overview of Pib2 architecture and of the fragments used for genetic studies.  907 
F) Summary of yeast-two-hybrid interactions between Pib2 fragments and the TORC1 subunit Kog1 908 
(Figure 6 – figure supplement 1). Fragments indicated by a black box interacted with Kog1, 909 
fragments indicated by a white box did not. 910 
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G) pib2Δ cells expressing the indicated Pib2 fragments from plasmids (see E) were assayed for their 911 
sensitivity to rapamycin (2.5 or 5 ng/ml) as in C.  912 
H) WT or pib2Δ cells expressing the indicated Pib2 fragments from plasmids were asseyed as in G, 913 
except that cells were spotted on synthetic medium to apply a selective pressure for plasmid 914 
maintenance. 915 
Figure 6 – figure supplement 1 916 
A) Transposon coverage of the PIB2 gene. Top row is the rapamycin treated library and rows below 917 
are presented as in Figure 2-5. The gray scale has been adjusted to account for the large number of 918 
sequencing reads mapping in the 5’ region of the gene. 919 
B) Yeast-two-hybrid assay assessing the interaction of the indicated Pib2 fragments encoded on the 920 
pCAB plasmid, with full-length Kog1 encoded on the pPR3N plasmid. 921 
C) gtr1Δ gtr2Δ cells expressing indicated, plasmid-encoded Pib2 fragments (see Figure 6E) were 922 
assayed for their sensitivity to rapamycin. Note that expressing Pib2Δ533-620 in gtr1Δ gtr2Δ cells appears 923 
to inhibit growth even in the absence of rapamycin. 924 
D) gtr1Δ gtr2Δ cells, transformed with centromeric plasmids expressing Pib2 fragments (see Figure 925 
6E) and alleles of Gtr1 and Gtr2 as indicated, were assayed for their sensitivity to rapamycin. 926 
Supplementary File 1 927 
Processed dataset containing (1) the position and number of reads for all transposons in each library 928 
(in the WIG format),  929 
• Processed dataset - Dpl1del.wig 930 
• Processed dataset - Mmm1Del_Vps13D716H.wig 931 
• Processed dataset - Psd2Del_Dpl1del.wig 932 
• Processed dataset - V13D716H.wig 933 
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• Processed dataset - WildType1.wig 934 
• Processed dataset - WildType2.wig 935 
• Processed dataset - WT_plus_rapamycin.wig 936 
• Processed dataset - Yen1on.wig 937 
(2) summaries of the number of transposon and number of reads per gene, for all genes in each 938 
library (in the TXT format).  939 
• Processed dataset - Dpl1del_pergene.txt 940 
• Processed dataset - Mmm1Del_Vps13D716H_pergene.txt 941 
• Processed dataset - Psd2Del_Dpl1del_pergene.txt 942 
• Processed dataset - V13D716H_pergene.txt 943 
• Processed dataset - WildType1_pergene.txt 944 
• Processed dataset - WildType2_pergene.txt 945 
• Processed dataset - WT_plus_rapamycin_pergene.txt 946 
• Processed dataset - Yen1on_pergene.txt 947 
 948 
Supplementary File 2 949 
Table of genes appearing as essential in our analysis (i.e., their density of transposon is below 1/400 950 
bp), but were not previously annotated as essential. The likely explanation for the low transposon 951 
density is written in column B for each gene. 952 
Supplementary File 3 953 
Data computed to draw the volcano plots (Figure 4 – figure supplement 1) 954 
  955 
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Tables 956 
Table 1: Characteristics of the libraries 957 
library Number of colonies reads mapped transposons mapped median read per transposon 
number of 
MiSeq runs 
overlap between MiSeq 
runs 
Wild-type 1 ~1.6x106 31794831 284162 22 2(1) 54%, 88%(1)
Wild-type 2 ~2.4x106 15303285 258568 12 1 NA 
VPS13(D716H) ~4.7x106 24958456 414114 13 2(2) 41%, 42%(2)
Mmm1Δ 
VPS13(D716H) 
~1.9x106 17799948 303323 12 1 NA 
dpl1Δ ~2.3x106 15077156 401126 8 1 NA 
dpl1Δ psd2Δ ~2.9x106 11649561 363179 9 1 NA 
YEN1on ~2.8x106 9517877 495125 6 1 NA 
Wild-type 2 + rapamycin ~2.4x106 9664956 169322 9 1 NA 
 958 
(1) The harvested library was grown in two flasks, one at 30˚C and the other at 37˚C. DNA was 959 
extracted separately from the two cultures and sequenced in two separate MiSeq runs 960 
(2) The library was harvested as ten subpools, which were grown in ten separate flasks. DNA was 961 
extracted separately. In one case, DNA from all ten subpools was pooled and processed to sequencing 962 
in one MiSeq run. In the other case,  DNAs were kept separate and processed until the PCR step (1x 963 
100 μl PCR by subpool). PCR products were pooled and sequenced as another MiSeq run. 964 
  965 
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Table 2: Yeast strains used in this study.  966 
*ADE2 deleted -56 before ATG + 62 after STOP with PCR primers #6 and #7 on pFA6a-His3MX6. 967 
Name Parent Genotype Reference 
CWY1 BY4723 MATa his3Δ0 ura3Δ0 ade2:Ds-1 Weil et al., 2000
ByK157 BY4743 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 VPS13(D716H) Lang et al. 2015
ByK352 BY4741 MATa his3Δ1 leu2Δ0 met17Δ0 ura3Δ0 ade2Δ::HIS3* This study  
ByK484 By4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 ade2Δ::HIS3* This study  
ByK485 ByK352 and ByK484 MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 
ade2Δ::HIS3*/ade2Δ::HIS3* 
This study 
ByK446 ByK157 MATα his3Δ1 leu2Δ0 ura3Δ0 ade2Δ::HIS3* VPS13(D716H) This study  
ByK528 ByK446 MATα his3Δ1 leu2Δ0 ura3Δ0 ade2Δ::HIS3* VPS13(D716H) mmm1Δ::KanMX6 This study  
ByK530 ByK352 MATa his3Δ1 leu2Δ0 met17Δ0 ura3Δ0  ade2Δ::NAT* dpl1Δ::KanMX6 This study  
ByK533 ByK352  MATa his3Δ1 leu2Δ0 met17Δ0 ura3Δ0 ade2Δ::HIS3* psd2Δ::KanMX6 dpl1Δ::NAT This study  
ByK576 ByK485 MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 
ade2Δ::HIS3*/ade2Δ::HIS3* prp45Δ::KanMX6/PRP45 
This study 
ByK579 ByK485 MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 
ade2Δ::HIS3*/ade2Δ::HIS3* PRP451-462-HA(KanMX6)/ PRP45 
This study 
ByK583 ByK485 MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 
ade2Δ::HIS3*/ade2Δ::HIS3* taf3Δ::KanMX6/TAF3 
This study 
ByK588 ByK485 MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 
ade2Δ::HIS3*/ade2Δ::HIS3* TAF31-270-HA(KanMX6)/ TAF3 
This study 
ByK725 ByK533 and ByK484 MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 
ade2Δ::HIS3*/ade2Δ::HIS3* psd2Δ::KanMX6/PSD2 dpl1Δ::NAT /DPL1 
This study 
ByK726 ByK533 and ByK484 MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 
ade2Δ::HIS3*/ade2Δ::HIS3* psd2Δ::KanMX6/PSD2 dpl1Δ::NAT /DPL1 
This study 
ByK739 ByK725 MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 
ade2Δ::HIS3*/ade2Δ::HIS3* psd2Δ::KanMX6/PSD2 dpl1Δ::NAT /DPL1 cdc10Δ::URA3/CDC10  
This study 
ByK740 ByK726 MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 
ade2Δ::HIS3*/ade2Δ::HIS3* psd2Δ::KanMX6/PSD2 dpl1Δ::NAT /DPL1 cdc10Δ::URA3/CDC10  
This study 
ByK741 ByK726 MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 
ade2Δ::HIS3*/ade2Δ::HIS3* psd2Δ::KanMX6/PSD2 dpl1Δ::NAT /DPL1 cdc10Δ::URA3/CDC10 
This study 
YJM3916 ByK352 MATa his3Δ1 leu2Δ0 met17Δ0 ura3Δ0 ade2Δ::HIS3* YEN1on This study 
YL516 BY4741/BY4742 MATa his3Δ1 leu2Δ0 ura3Δ0 Binda et al, 2009
MB32 YL516 MATa his3Δ1 leu2Δ0 ura3Δ0 gtr1Δ::kanMX Binda et al, 2009
RKH106 YL516 MATa his3Δ1 leu2Δ0 ura3Δ0 pib2Δ::kanMX This study 
RKH241 MB32 MATa his3Δ1 leu2Δ0 ura3Δ0 gtr1Δ::kanMX gtr2Δ::hphMX4 This study 
NMY51  his3Δ200 trp1-901 leu2-3,112 ade2 LYS::(lexAop)4-HIS3 ura3::(lexAop)8- lacZ ade2::(lexAop)8-
ADE2 GAL4 
Dualsystems Biotech AG
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Table 3: Oligonucleotides used in this study.  968 
 969 
# Original name Sequence Purpose 
1 P5_MiniDs AATGATACGGCGACCACCGAGATCTACtccgtcccgcaagttaaata amplify library 
2 MiniDs_P7 CAAGCAGAAGACGGCATACGAGATacgaaaacgaacgggataaa amplify library 
3 688_minidsSEQ1210 tttaccgaccgttaccgaccgttttcatcccta sequence library 
4 ADE2Fwd GGTTCGAGCTCCCTTTTGATGCGGAATTGAC clone ADE2 MiniDS 
5 ADE2Rev GACCTGAGCTCTTACTGGATATGTATGTATG clone ADE2 MiniDS 
6 Ade2PriFwd GTATAAATTGGTGCGTAAAATCGTTGGATCTCTCTTCTAAcggatccccgggttaattaa delete ADE2 
7 Ade2PriRev TATGTATGAAGTCCACATTTGATGTAATCATAACAAAGCCgaattcgagctcgtttaaac delete ADE2  
8 Dpl1_Janke_S1 AGCAAGTAGGCTAGCTTCTGTAAAGGGATTTTTCCATCTAATACAcgtacgctgcaggtcgac delete DPL1 
9 Dpl1_Janke_S2 GCACTCTCGTTCTTTAAATTATGTATGAGATTTGATTCTATATAGatcgatgaattcgagctcg delete DPL1 
10 Psd2_pringle_F GATGCTGTATCAATTGGTAAAGAATCCTCGATTTTCAGGAGCATCCAACGcgtacgctgcaggtcgac delete PSD2 
11 Psd2_pringle_R CTTGTTTGTACACGCTATAGTCTATAATAAAGTCTGAGGGAGATTGTTCATGatcgatgaattcgagctcg delete PSD2 
12 TAF3_R1 TGGATGAGATAATGACGAAAGAAAATGCAGAAATGTCGTTgaattcgagctcgtttaaac TAF3 partial deletion 
13 TAF3_aa90_F2 AGGTATTGTTAAGCCTACGAACGTTCTGGATGTCTATGATcggatccccgggttaattaa TAF3 partial deletion 
14 Taf3_Fwd GGCAAGATGTGATCAGGACG check TAF3 partial deletion
15 Taf3_Rev TCTTGAAGAAGCGAAAGTACACT check TAF3 partial deletion
16 TAF3_R1 TGGATGAGATAATGACGAAAGAAAATGCAGAAATGTCGTTgaattcgagctcgtttaaac TAF3 complete deletion  
 
17 TAF3_aa1_ 
F1 
GAAAACAGCGATATCTTTGGGTCAATAGAGTTCCTCTGCTtgaggcgcgccacttctaaa TAF3 complete deletion  
18 PRP45_R1 ACTCAAGCACAAGAATGCTTTGTTTTCCTAGTGCTCATCCTGGGCgaattcgagctcgtttaaac PRP45 partial deletion 
19 PRP45_aa154_F2 AACGACGAAGTCGTGCCTGTTCTCCATATGGATGGCAGCAATGATcggatccccgggttaattaa PRP45 partial deletion 
20 PRP45_Fwd AGGTTGTAGCACCCACAGAA check PRP45 partial deletion
21 PRP45_Rev CAATCATCACACCTCAGCGA check PRP45 partial deletion
22 PRP45_R1 ACTCAAGCACAAGAATGCTTTGTTTTCCTAGTGCTCATCCTGGGCgaattcgagctcgtttaaac PRP45 complete deletion 
23 PRP45_aa1_F1 GCTCTGAGCCGAGAGGACGTATCAGCAACCTCAACCAAATtgaggcgcgccacttctaaa PRP45 complete deletion  
 
24 CDC10-Ura3_fwd AAGGCCAAGCCCCACGGTTACTACAAGCACTCTATAAATATATTAtgacggtgaaaacctctgac CDC10 complete deletion 
25 URA3-CDC10_rev TTCTTAATAACATAAGATATATAATCACCACCATTCTTATGAGATtcctgatgcggtattttctcc CDC10 complete deletion 
26 OJM370  ATGGGTGTCTCACAAATATGGG Amplify YEN1 
27 OJM371 TTCAATAGTGCTACTGCTATCAC Amplify YEN1 
28 OJM372 TTCAATAGTGCTACTGCTATCACTGTCACAGGCTCAAACCGGTCGACTG 
TTCGTACGCTGCAGGTCGAC 
Delitto perfetto  on YEN1 
29 OJM373 ATGGGTGTCTCACAAATATGGGAATTTTTGAAGCCATATCTGCAAGATTCCCGCGCGTTGGCCGATT
CAT 
Delitto perfetto  on YEN1 
30 o3958 gacggtatcgataagcttgatatcgGCGCTGGCATCTTTAATCTC PIB2 cloning 
31 o3959 actagtggatcccccgggctgcaggTGCTTGGATCCTTCTTGGTC PIB2 cloning 
32 o3224 TAATA CGACT CACTA TAGGG various PIB2 truncations 
33 o3225 ATTAA CCCTC ACTAA AGGGA A various PIB2 truncations 
34 o4034 atctagttcagggttcgacattctggtctccactac PIB2165-635 truncation 
35 o4010 gtagtggagaccagaatgtcgaaccctgaactagat PIB2165-635 truncation 
36 o4012 tagtggagaccagaatgttaccgcagcctgct PIB2304-635 truncation 
37 o4035 tcaaattagaactagcattcattctggtctccactacaactgtg PIB2221-635 truncation 
38 o4011 cacagttgtagtggagaccagaatgaatgctagttctaatttga PIB2221-635 truncation 
39 o4062 atagttggtattaagttgattctcattctggtctccactacaactg PIB2426-635 truncation 
40 o3996 cagttgtagtggagaccagaatgagaatcaacttaataccaactat PIB2426-635 truncation 
41 o4063 cgtgtttgcgttatggttgtcgctgttcggaataga PIB2Δ426-532 truncation 
42 o3997 tctattccgaacagcgacaaccataacgcaaacacg PIB2Δ426-532 truncation 
43 o4064 cacagagccgataacactcgtggttgaaaggttctc PIB2Δ533-620 truncation 
44 o3998 gagaacctttcaaccacgagtgttatcggctctgtg PIB2Δ533-620 truncation 
45 o4065 gtctcgcaaaaaatgttcatcagcccaaaacatcattaccttct PIB21-620 truncation 
46 o3999 agaaggtaatgatgttttgggctgatgaacattttttgcgagac PIB21-620 truncation 
47 o1440 GCTAGAGCGGCCATTACGGCCCCGGAGATTTATGGACCTC KOG1 cloning  into pPR3N
48 o1442 CGATCTCGGGCCGAGGCGGCCTCAAAAATAATCAATTCTCTCGTC KOG1 cloning into pPR3N 
49 o3787 GCTAGAGCGGCCATTACGGCC GAATTGTACAAATCTAGAACTAGT cloning PIB2 fragments into pCabWT*
50 o3788 CGATCTCGGGCCGAGGCGGCCAA GAAACTACTCCAATTCCAGTTTGC cloning PIB2 fragments into pCabWT*
51 o3872 CGATCTCGGGCCGAGGCGGCCAAGCCCAAAACATCATTACCTTCTTCT cloning PIB2 fragments into pCabWT*
52 o3871 CGATCTCGGGCCGAGGCGGCCAAATCTTCGCCCTCCTCAACGT cloning PIB2 fragments into pCabWT*
53 o3870 CGATCTCGGGCCGAGGCGGCCAAGTTGATTCTGTCGCTGTTCG cloning PIB2 fragments into pCabWT*
54 o3933 GCTAGAGCGGCCATTACGGCCAGGAAGAAATTACGCAATTACTAC cloning PIB2 fragments into pCabWT*
 
 
45 
Oligonucleotides #1 and #2, ordered as PAGE-purified and lyophilized, are resuspended at 100 μM in 970 
water. Oligonucleotide #3, ordered as HPLC-purified and lyophilized, is resuspended at 100 μM in 971 
water and distributed into single-use aliquots.   972 
55 o3934 GCTAGAGCGGCCATTACGGCC AGTGTTATCGGCTCTGTGCC cloning PIB2 fragments into pCabWT*
56 o3868 CGATCTCGGGCCGAGGCGGCCAAATTAGTGCTCGAAGCAGGCT cloning PIB2 fragments into pCabWT*
57 o3867 CGATCTCGGGCCGAGGCGGCCAAGTCATCCGTGAATGGCAACG cloning PIB2 fragments into pCabWT*
58 o3866 CGATCTCGGGCCGAGGCGGCCAAGCCTGCCCCTGTTGAGCTCT cloning PIB2 fragments into pCabWT*
59 o3865 CGATCTCGGGCCGAGGCGGCCAAGTCAGCACCGCTTTCCTCAT cloning PIB2 fragments into pCabWT*
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Table 4: Plasmids used in this study.  973 
 974 
Name Parent Description Reference 
pBK257 pWL80R_4x CEN/URA3, carries MiniDs in ADE2 and hyperactive Ac transposase under GAL1 
promoter 
This study 
pWL80R_4x  CEN/URA3, carries hyperactive Ac transposase under GAL1 promoter Lazarow et al. 2012 
pCORE-UH  Delitto pefetto URA3 cassette Storici et al. 2003 
pJM7  pENTRY-YEN1ON This study 
pRS413  CEN/HIS3, empty vector Sikorski et al., 1989  
pRS415  CEN/LEU2, empty vector Sikorski et al., 1989  
pRS416  CEN/URA3, empty vector Sikorski et al., 1989  
p1822 pRS413 CEN/HIS3, GTR1 This study 
p1451 pRS415 CEN/LEU2, GTR2 This study 
p1821 pRS413 CEN/HIS3, GTR1Q65L This study 
p1452 pRS415 CEN/LEU2, GTR2S23L This study 
p3084 pRS416 CEN/URA3, PIB2 This study 
p3099 p3084 CEN/URA3, PIB2165-635 This study 
p3097 p3084 CEN/URA3, PIB2304-635 This study 
p3101 p3084 CEN/URA3, PIB2221-635 This study 
p3253 pRS426 2μ/URA3, PIB2 This study 
p3255 pRS426 2μ/URA3, PIB2165-635 This study 
p3163 p3084 CEN/URA3, PIB2426-635 This study 
p3153 p3084 CEN/URA3, PIB2Δ426-532 This study 
p3154 p3084 CEN/URA3, PIB2Δ533-620 This study 
p3156 p3084 CEN/URA3, PIB21-620 This study 
pPR3N  2μ/TRP1, NubG-HA Dualsystems Biotech AG
pCabWT  CEN/LEU2, Aβ-Cub-LexA-VP16 Dualsystems Biotech AG
p3081 pPR3N 2μ/TRP1, NubG-HA-KOG1 This study 
p2966 pCabWT CEN/LEU2, Aβ-PIB2-Cub-LexA-VP16 This study 
p3002 pCabWT CEN/LEU2, Aβ-PIB21-620-Cub-LexA-VP16 This study 
p3007 pCabWT CEN/LEU2, Aβ-PIB21-550-Cub-LexA-VP16 This study 
p3001 pCabWT CEN/LEU2, Aβ-PIB21-428-Cub-LexA-VP16 This study 
p3051 pCabWT CEN/LEU2, Aβ-PIB2440-550-Cub-LexA-VP16 This study 
p3054 pCabWT CEN/LEU2, Aβ-PIB2556-620-Cub-LexA-VP16 This study 
p3052 pCabWT CEN/LEU2, Aβ-PIB2621-635-Cub-LexA-VP16 This study 
p3000 pCabWT CEN/LEU2, Aβ-PIB21-312-Cub-LexA-VP16 This study 
p2987 pCabWT CEN/LEU2, Aβ-PIB2304-635-Cub-LexA-VP16 This study 
p2999 pCabWT CEN/LEU2, Aβ-PIB21-162-Cub-LexA-VP16 This study 
p2986 pCabWT CEN/LEU2, Aβ-PIB2165-635-Cub-LexA-VP16 This study 
p2998 pCabWT CEN/LEU2, Aβ-PIB21-101-Cub-LexA-VP16 This study 
p2991 pCabWT CEN/LEU2, Aβ-PIB2102-635-Cub-LexA-VP16 This study 
p2997 pCabWT CEN/LEU2, Aβ-PIB21-49-Cub-LexA-VP16 This study 
p2990 pCabWT CEN/LEU2, Aβ-PIB250-635-Cub-LexA-VP16 This study 
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